why choose us

First received: March 19, 2024

Clinical Trial: A Study To Evaluate The Treatment Pattern Of Moderate-to-Severe Asthma Patients In China

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Moderate-to-Severe Asthma

Study Type: OBSERVATIONAL


Official Title: A Prospective, Observational, Multicentre Study To Evaluate The Treatment Pattern Of Moderate-to-Severe Asthma Patients In China

Brief Summary: This is a Prospective, Observational, Multicentre Study to describe treatment pattern changes of uncontrolled moderate-to-severe asthma patients in China.Sponsor by Astrazeneca Investment(China) Co., LTD.

Read more